Pluristem Therapeutics Inc (PSTI)

[Scott999]

I do not agree in the least. If you got a call and was told someone was in an accident and are undergoing surgery, you would think they're in surgery right now hands down. You wouldn't think they are prepping the tools, or cleaning the OR, but they are cut open and getting fixed. But enough on that topic. Here's a real one.

Why is there a delay in getting this thing started? It is obvious that both sides want to get this started asap. My only concern is the government is playing hardball, knowing Pluristem desperately needs this to continue operations into the future.

Could their stumble in not getting a contract for the first two phases be hindering the negotiations. They let the government pay for the study costs without getting any direct development compensation. Is the government asking for a similar deal?

I have no clue how much doing an NHP trial would cost. I don't think either of the first two phases' costs would come even close to the lower contracts of $50 million that competing companies received. Even a 150 NHP wouldn't cost that much would it? But again I have no idea.

And I believe the holdup for closing the Sosei deal rests on them having a substantial increase in cash in their coffers. So much is depending on this contract.

All I know is that it's been over 4 months since dosing trial was competed. That seems like an eternity considering the potential threats this world is facing, and the obvious need for a potential cure for ARS.

I believe we will be able to tell the caliber of our management by the terms of this contract. A $40+ million deal would be a win. A paid trial would be a fail. Still great either way as we need to get this started. But a true test of our managements skills.

All IMO of course.